{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:55:18Z","timestamp":1768870518476,"version":"3.49.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background and objectives<\/jats:title>\n                    <jats:p>People living with HIV (PLWH) are increasingly at risk for cardiovascular disease (CVD) due to chronic inflammation, metabolic dysregulation, and long-term antiretroviral therapy (ART). However, limited data exist regarding coronary anatomy and long-term outcomes in PLWH with acute coronary syndrome (ACS), particularly in Chinese populations. This study aimed to compare coronary angiographic characteristics, metabolic-inflammatory profiles, and 2-year prognosis between PLWH and HIV-uninfected patients with ACS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a single-center observational cohort study including 129 patients with a first episode of ACS between 2019 and 2023. 43 PLWH were analyzed with 86 HIV-uninfected controls. Coronary artery lesions were assessed by angiography and SYNTAX score. Laboratory parameters including CRP and lipid levels, among others, were collected. The primary outcome was the incidence of major adverse cardiovascular and cerebrovascular events during the 2-year follow-up period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      PLWH had significantly higher SYNTAX scores compared to HIV-free patients (21.56 vs. 16.77,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.001). They also showed elevated levels of LDL-C (3.18 vs. 2.66\u2005mmol\/L,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.009) and CRP (median 9.10 vs. 5.10\u2005mg\/L,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001). At 2 years, PLWH had a higher rate of ACS recurrence (18.6% vs. 7.0%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.089), but mortality and other adverse events were similar. In multivariate analyses, HIV status was not an independent predictor of relapse, while calcified lesions were significantly associated with relapse.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PLWH with ACS have more complex coronary heart disease and a higher risk of recurrence, partly due to vascular calcific changes. These findings suggest the need for enhanced metabolic monitoring and individualized secondary prevention strategies in this high-risk population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2025.1702174","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T12:01:35Z","timestamp":1768824095000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Coronary complexity and inflammatory burden in HIV-infected patients with acute coronary syndrome: a two-year prospective cohort study in China"],"prefix":"10.3389","volume":"12","author":[{"given":"Qiang","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Geriatrics, National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, the Second Hospital Affiliated of Southern University of Science and Technology","place":["Shenzhen, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqin","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, the Second Hospital Affiliated of Southern University of Science and Technology","place":["Shenzhen, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunxiao","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, the Second Hospital Affiliated of Southern University of Science and Technology","place":["Shenzhen, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Liver Diseases, Shenzhen Third People\u2019s Hospital","place":["Shenzhen, China"]},{"name":"Medical Affairs Department, Shenzhen Third People\u2019s Hospital","place":["Shenzhen, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siwei","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, the Second Hospital Affiliated of Southern University of Science and Technology","place":["Shenzhen, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhui","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, the Second Hospital Affiliated of Southern University of Science and Technology","place":["Shenzhen, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niuniu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, the Second Hospital Affiliated of Southern University of Science and Technology","place":["Shenzhen, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, the Second Hospital Affiliated of Southern University of Science and Technology","place":["Shenzhen, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meixia","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, the Second Hospital Affiliated of Southern University of Science and Technology","place":["Shenzhen, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianjia","family":"Ning","sequence":"additional","affiliation":[{"name":"Center of Clinical Epidemiology , Shenzhen Third People's Hospital, the Second Hospital Affiliated of Southern University of Science and Technology","place":["Shenzhen, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinghua","family":"Wang","sequence":"additional","affiliation":[{"name":"Center of Clinical Epidemiology , Shenzhen Third People's Hospital, the Second Hospital Affiliated of Southern University of Science and Technology","place":["Shenzhen, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, the Second Hospital Affiliated of Southern University of Science and Technology","place":["Shenzhen, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, the Second Hospital Affiliated of Southern University of Science and Technology","place":["Shenzhen, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, the Second Hospital Affiliated of Southern University of Science and Technology","place":["Shenzhen, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC guidelines for the management of acute coronary syndromes","volume":"13","author":"Byrne","year":"2024","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"B2","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1093\/eurheartj\/ehab892","article-title":"European society of cardiology: cardiovascular disease statistics 2021","volume":"43","author":"Timmis","year":"2022","journal-title":"Eur Heart J"},{"key":"B3","article-title":"Global Hiv & Aids Statistics \u2014 Fact Sheet Unaids","year":"2021"},{"key":"B4","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/S1473-3099(15)00056-0","article-title":"Future challenges for clinical care of an ageing population infected with HIV: a modelling study","volume":"15","author":"Smit","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/s41569-019-0219-9","article-title":"HIV infection and coronary heart disease: mechanisms and management","volume":"16","author":"Hsue","year":"2019","journal-title":"Nat RevCardiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1161\/ATVBAHA.122.318232","article-title":"Cardiovascular disease and thrombosis in HIV infection","volume":"43","author":"Perkins","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1161\/01.CIR.0000114520.38748.AA","article-title":"Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection","volume":"109","author":"Hsue","year":"2004","journal-title":"Circulation"},{"key":"B8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.atherosclerosis.2015.03.019","article-title":"High prevalence at computed coronary tomography of non-calcif plaques in asymptomatic HIV patients treated with HAART: a meta-analysis","volume":"240","author":"D'Ascenzo","year":"2015","journal-title":"Atherosclerosis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e012241","DOI":"10.1161\/JAHA.119.012241","article-title":"HIV infection and incidence of cardiovascular diseases: an analysis of a large healthcare database","volume":"8","author":"Alonso","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1161\/CIRCULATIONAHA.117.033369","article-title":"Global burden of atherosclerotic cardiovascular disease in people living with HIV: systematic review and meta-analysis","volume":"138","author":"Shah","year":"2018","journal-title":"Circulation"},{"key":"B11","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ramb.2012.11.003","article-title":"Lipid profile of HIV-infected patients in relation to antiretroviral therapy: a review","volume":"59","author":"Souza","year":"2013","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12879-023-08910-9","article-title":"Dyslipidemia among HIV-infected patients in Ethiopia: a systematic review and meta-analysis","volume":"24","author":"Mohammed","year":"2024","journal-title":"BMC Infect Dis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e0250328","DOI":"10.1371\/journal.pone.0250328","article-title":"Prevalence of dyslipidaemia among HIV-infected patients receiving combination antiretroviral therapy in North Shewa, Ethiopia","volume":"16","author":"Fiseha","year":"2021","journal-title":"PLoS One"},{"key":"B14","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1097\/QAI.0000000000001450","article-title":"Increased risk of myocardial infarction in HIV-infected individuals in North America compared with the general population","volume":"75","author":"Drozd","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e000844","DOI":"10.1161\/JAHA.114.000844","article-title":"Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation","volume":"3","author":"Nordell","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1056\/NEJMoa062360","article-title":"Cd4+ count-guided interruption of antiretroviral treatment","volume":"355","author":"El-Sadr","year":"2006","journal-title":"N Engl J Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"8451","DOI":"10.1038\/ncomms9451","article-title":"HIV-tuberculosis-associated immune reconstitution inflammatory syndrome is characterized by toll-like receptor and inflammasome signalling","volume":"6","author":"Lai","year":"2015","journal-title":"Nat Commun"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1093\/infdis\/jiu238","article-title":"Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection","volume":"210","author":"Hunt","year":"2014","journal-title":"J Infect Dis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3390\/jcm8081109","article-title":"Inflammation as a therapeutic target in atherosclerosis","volume":"8","author":"Nguyen","year":"2019","journal-title":"J Clin Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"50","DOI":"10.4244\/EIJV5I1A9","article-title":"Assessment of the syntax score in the syntax study","volume":"5","author":"Serruys","year":"2009","journal-title":"EuroIntervention"},{"key":"B21","first-page":"219","article-title":"The syntax score: an angiographic tool grading the complexity of coronary artery disease","volume":"1","author":"Sianos","year":"2005","journal-title":"Eurointervention"},{"key":"B22","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(13)60141-5","article-title":"Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomized,clinical syntax tria","volume":"381","author":"Mohr","year":"2013","journal-title":"Lancet"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.4244\/EIJ-D-15-00409","article-title":"Quantitative angiographic characterisation of coronary artery disease in patients with human immunodeficiency virus (HIV) infection undergoing percutaneous coronary intervention","volume":"12","author":"Theodoropoulos","year":"2017","journal-title":"EuroIntervention"},{"key":"B24","doi-asserted-by":"publisher","first-page":"8351304","DOI":"10.1155\/2022\/8351304","article-title":"Assessment of clinical features in HIV-infected patients with acute coronary syndromes undergoing percutaneous coronary intervention in China","volume":"2022","author":"Liu","year":"2022","journal-title":"J Interv Cardiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1097\/QAD.0000000000002297","article-title":"Coronary atherosclerosis characteristics in HIV-infected patients on long-term antiretroviral therapy: insights from coronary computed tomography\u2013angiography","volume":"33","author":"Senoner","year":"2019","journal-title":"AIDS"},{"key":"B26","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1001\/archinte.163.4.457","article-title":"Acute myocardial infarction in human immunodeficiency virus-infected patients","volume":"163","author":"Matetzky","year":"2003","journal-title":"Arch Intern Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/eurheartj\/ehq372","article-title":"Acute coronary syndrome in human immunodeficiency virus-infected patients: characteristics and 1 year prognosis","volume":"32","author":"Boccara","year":"2011","journal-title":"Eur Heart J"},{"key":"B28","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.atherosclerosis.2008.10.012","article-title":"Human immunodeficiency virus per se exerts atherogenic effects","volume":"204","author":"Oliviero","year":"2009","journal-title":"Atherosclerosis"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1111\/jce.16076","article-title":"Catheter ablation approach and outcome in HIV+ patients with recurrent atrial fibrillation","volume":"34","author":"La Fazia","year":"2023","journal-title":"J Cardiovasc Electrophysiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1086\/381783","article-title":"Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?","volume":"189","author":"Fontas","year":"2004","journal-title":"J Infect Dis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1468-1293.2005.00316.x","article-title":"Antiretroviral therapy in HIV-positive men is associated with increased apolipoprotein CIII in triglyceride-rich lipoproteins","volume":"6","author":"Rimland","year":"2005","journal-title":"HIV Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/00005082-200505000-00005","article-title":"Coronary artery calcium in HIV-infected men treated with highly active antiretroviral therapy","volume":"20","author":"Robinson","year":"2005","journal-title":"J Cardiovasc Nurs"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e0226924","DOI":"10.1371\/journal.pone.0226924","article-title":"HIV Antiretroviral drugs, dolutegravir, maraviroc and ritonavir-boosted atazanavir use different pathways to affect inflammation, senescence and insulin sensitivity in human coronary endothelial cells","volume":"15","author":"Auclair","year":"2020","journal-title":"PLoS One"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1038\/labinvest.2009.85","article-title":"Highly active antiretroviral therapy drugs inhibit in vitro cholesterol efflux from human macrophage-derived foam cells","volume":"89","author":"Wang","year":"2009","journal-title":"Lab Invest"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1702174\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T12:01:36Z","timestamp":1768824096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1702174\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":34,"alternative-id":["10.3389\/fcvm.2025.1702174"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1702174","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,19]]},"article-number":"1702174"}}